Table 1.
Patients characteristics
| Patients (n = 32) | |
|---|---|
| Age | |
| ≥65 | 10(31.3%) |
| <65 | 22(68.7%) |
| Sex | |
| Male | 24(75%) |
| Female | 8(25%) |
| Smoking status | |
| Current or former smoker | 16(50%) |
| Never smoked | 16(50%) |
| Preoperative nodal stage | |
| N1 | 21(65.6%) |
| N2 | 11(34.4%) |
| Stage at presentation* | |
| IIA | 12(37.5%) |
| IIB | 9(28.1%) |
| IIIA | 11(34.4%) |
| Cancer type | |
| Adenocarcinoma | 13(40.6%) |
| Squamous cell carcinoma | 19(59.4%) |
| PD-L1 expressiona | |
| >1% | 17(53.1%) |
| ≤1% | 15(46.9%) |
| ECOG Physical Score | |
| 0 | 18(56.3%) |
| 1 | 14(43.7%) |
| TMB (Tumor mutational burden) | |
| >5.7 | 16(50%) |
| ≤5.7 | 16(50%) |
Data are median (IQR) or n (%).
*
Classified on the basis of the American Joint Committee on Cancer 8th edition staging system.
a
Measured by use of the 22C3 pharmDx kit.